Cresco Labs Inc.
CL.CNCNQHealthcare● Active
$1.29
+$0.05(+4.03%)
Market Cap$456951002
P/E Ratio—
52W High$3.12
52W Low$0.6
Cresco Labs Inc. (CL.CN) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CL.CN · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.67B | $0.72B | $0.77B | $0.84B | $0.82B |
| Cost of Revenue | $0.33B | $0.36B | $0.41B | $0.44B | $0.42B |
| Gross Profit | $0.32B | $0.36B | $0.36B | $0.41B | $0.41B |
| Gross Margin %(computed) | 48.64% | 50.32% | 47.01% | 48.30% | 49.45% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.23B | $0.27B | $0.05B | $0.04B |
| Total Operating Expenses | $0.25B | $0.26B | $0.45B | $0.49B | $0.62B |
| Operating Income | $0.08B | $0.11B | ($0.09B) | ($0.08B) | ($0.22B) |
| Operating Margin %(computed) | 11.53% | 14.81% | -11.39% | -10.00% | -26.45% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.06B | $0.06B | $0.06B | $0.06B | $0.05B |
| Income Before Tax | ($0.10B) | ($0.01B) | ($0.15B) | ($0.13B) | ($0.26B) |
| Income Tax Expense | $0.04B | $0.05B | $0.03B | $0.09B | $0.04B |
| Net Income | ($0.14B) | ($0.07B) | ($0.18B) | ($0.21B) | ($0.32B) |
| Net Margin %(computed) | -20.65% | -10.28% | -22.77% | -25.16% | -38.90% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.42 | $-0.22 | $-0.53 | $-0.71 | $-1.22 |
| Wtd Avg Shares | 0.34B | 0.35B | 0.32B | 0.30B | 0.26B |
| EBITDA | $0.02B | $0.11B | ($0.01B) | ($0.01B) | ($0.16B) |
| EBITDA Margin %(computed) | 3.05% | 15.78% | -1.81% | -1.27% | -19.43% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Cresco Labs Inc. data
About Cresco Labs Inc. (CL.CN) Income Statement
Cresco Labs Inc. (CL.CN) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, CL.CN reported revenue of $0.67B, gross profit of $0.32B (gross margin 48.64%), and net income of ($0.14B) — a net profit margin of -20.65%.
Frequently asked questions
CL.CN · 4 questionsCresco Labs Inc. (CL.CN) reported revenue of $0.67B for 2025, down 7.9% year-over-year.
CL.CN revenueCL.CN salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08